Last reviewed · How we verify

NCT05923606

Modulation of Brain Oscillations Underlying Working Memory

Recruiting now NA Last updated 9 February 2026
What this trial tests

NA trial testing Active tACS in Working Memory in 32 participants. Currently enrolling.

Timeline
10 July 2024
Primary endpoint
31 August 2026
31 March 2027

Quick facts

Lead sponsorMassachusetts General Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposebasic science
Enrollment32
Start date10 July 2024
Primary completion31 August 2026
Estimated completion31 March 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts General Hospital

Who can join

Adults 18 to 35, any sex, with Working Memory. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will use novel transcranial alternating current stimulation (tACS) protocols and electroencephalography (EEG) to modulate and measure brain oscillations that underlie working memory. tACS is a noninvasive method used to modulate the timing and patterns of brain rhythms via weak electric currents passed through electrodes on the scalp.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Working Memory

Currently open trials in the same condition.

Other Massachusetts General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05923606.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing